BeStock  
Markets › Compare › MONOY vs IOVA

MONOY vs IOVA

Side-by-side comparison of price performance, valuation, growth, profitability, analyst targets and technical trend.

vsvs
MONOY · MonotaRO (ADR)$13.22 ▲ 1.61%
IOVA · Iovance Biotherapeutics$14.15 ▼ 0.46%

One year, rebased to 100

Each line starts at 100 so growth is directly comparable

38208377547716Oct 7, '25Apr 7, '26Oct 5, '26
  • MONOY -6.6%
  • IOVA +549.1%

Head to head

MetricMONOYIOVA
Price$13.22$14.15
Change today▲ 1.61%▼ 0.46%
Market cap$6.41B$6.41B
Return, 3 months+11.2%+225.3%
Return, year to date-16.8%+418.3%
Return, 1 year-8.4%+540.3%
P/E (TTM)28.1-20.5
P/B8.58.7
P/E percentile vs own 5y––
Dividend yield1.76%–
Revenue growth (YoY, latest qtr)––
Net profit growth (YoY)––
Gross margin––
Operating margin––
Net margin––
Return on equity––
Analyst target vs. price––
Analyst buy share––
RSI (14)6279
30-day volatility37.6%92.4%
Max drawdown, 1 year-34.9%-39.0%
Trend readStrong uptrendStrong uptrend
Analyst consensus––

Green cells mark the best value in each row where "better" is clear-cut (lower P/E, higher margin). That is a reading of the numbers, not a recommendation. Financials are in each company's reporting currency.

What the numbers say

  • IOVA is the largest of the group by market value.
  • IOVA has returned the most over the past year.
  • IOVA carries the lowest trailing P/E.
  • MONOY has been the calmest stock over the last 30 days.

Go deeper

Scroll to Top